CoronaVR
Image


Efficient MHC-I Binders


No Protein Epitope sequence Start Stop Length Allele Conservancy
1 S WTAGAAAYYV 258 267 10 HLA-A*68:02 60% (SARS-CoV)
2 S FPNITNLCPF 329 338 10 HLA-B*53:01 100% (SARS-CoV)
3 S FPNITNLCPF 329 338 10 HLA-B*35:01 100% (SARS-CoV)
4 S SPRRARSVA 680 688 9 HLA-B*07:02 55.56% (SARS-CoV)
5 S FVFLVLLPLV 2 11 10 HLA-A*02:06 60% (SARS-CoV)
6 S AEIRASANL 1016 1024 9 HLA-B*40:01 100% (SARS-CoV)
7 S SPRRARSVAS 680 689 10 HLA-B*07:02 50% (SARS-CoV)
8 S KSNLKPFER 458 466 9 HLA-A*31:01 55.56% (SARS-CoV)
9 S FAMQMAYRF 898 906 9 HLA-B*35:01 100% (SARS-CoV)
10 S FTISVTTEI 718 726 9 HLA-A*68:02 66.67% (SARS-CoV)
11 S KIYSKHTPI 202 210 9 HLA-A*32:01 55.56% (SARS-CoV)
12 S TTRTQLPPA 19 27 9 HLA-A*30:01 55.56% (SARS-CoV)
13 S FNATRFASV 342 350 9 HLA-B*08:01 77.78% (SARS-CoV)
14 S PYRVVVLSF 507 515 9 HLA-A*23:01 100% (SARS-CoV)
15 S VTLADAGFIK 826 835 10 HLA-A*11:01 90% (SARS-CoV)
16 S LLFNKVTLA 821 829 9 HLA-A*02:03 100% (SARS-CoV)
17 S GVYFASTEK 89 97 9 HLA-A*11:01 77.78% (SARS-CoV)
18 S FVFLVLLPLV 2 11 10 HLA-A*02:01 60% (SARS-CoV)
19 S LGAENSVAY 699 707 9 HLA-B*35:01 66.67% (SARS-CoV)
20 S IAIPTNFTI 712 720 9 HLA-B*58:01 88.89% (SARS-CoV), 88.89% (HKU1)
21 S YTSALLAGTI 873 882 10 HLA-A*68:02 60% (SARS-CoV)
22 S WTAGAAAYYV 258 267 10 HLA-A*02:06 60% (SARS-CoV)
23 S FVFLVLLPL 2 10 9 HLA-A*02:06 66.67% (SARS-CoV)
24 S KLNDLCFTNV 386 395 10 HLA-A*02:03 90% (SARS-CoV)
25 S NASVVNIQK 1173 1181 9 HLA-A*68:01 100% (SARS-CoV)
26 S FSTFKCYGV 374 382 9 HLA-A*68:02 100% (SARS-CoV)
27 S SLIDLQELGK 1196 1205 10 HLA-A*11:01 100% (SARS-CoV)
28 S VVFLHVTYV 1060 1068 9 HLA-A*02:03 100% (SARS-CoV)
29 S FVFLVLLPL 2 10 9 HLA-A*02:01 66.67% (SARS-CoV)
30 S LPFNDGVYF 84 92 9 HLA-B*35:01 66.67% (SARS-CoV)
31 S ITPCSFGGV 587 595 9 HLA-A*68:02 77.78% (SARS-CoV)
32 S NVTWFHAIHV 61 70 10 HLA-A*68:02 60% (SARS-CoV)
33 S VVFLHVTYV 1060 1068 9 HLA-A*02:06 100% (SARS-CoV)
34 S FVFLVLLPLV 2 11 10 HLA-A*02:03 60% (SARS-CoV)
35 S FKIYSKHTPI 201 210 10 HLA-A*02:03 50% (SARS-CoV)
36 S AALQIPFAM 892 900 9 HLA-B*35:01 100% (SARS-CoV)
37 S FVFLVLLPL 2 10 9 HLA-A*68:02 66.67% (SARS-CoV)
38 S FTISVTTEI 718 726 9 HLA-A*02:06 66.67% (SARS-CoV)
39 S LLIVNNATNV 117 126 10 HLA-A*02:03 60% (SARS-CoV)
40 S VLSFELLHA 512 520 9 HLA-A*02:03 88.89% (SARS-CoV)
41 S LLAGTITSG 877 885 9 HLA-A*02:03 66.67% (SARS-CoV)
42 E LLFLAFVVF 18 26 9 HLA-B*15:01 100% (SARS-CoV)
43 E FLAFVVFLLV 20 29 10 HLA-A*02:01 100% (SARS-CoV)
44 E RVKNLNSSR 61 69 9 HLA-A*31:01 88.89% (SARS-CoV)
45 E FLAFVVFLL 20 28 9 HLA-A*02:01 100% (SARS-CoV)
46 E TLAILTALR 30 38 9 HLA-A*68:01 100% (SARS-CoV)
47 E FLAFVVFLLV 20 29 10 HLA-A*02:03 100% (SARS-CoV)
48 E FLAFVVFLL 20 28 9 HLA-A*02:03 100% (SARS-CoV)
49 E VLLFLAFVV 17 25 9 HLA-A*02:01 100% (SARS-CoV)
50 E SVLLFLAFV 16 24 9 HLA-A*02:06 100% (SARS-CoV)
51 E NSVLLFLAFV 15 24 10 HLA-A*68:02 100% (SARS-CoV)
52 E FLLVTLAIL 26 34 9 HLA-A*02:01 100% (SARS-CoV)
53 E VLLFLAFVVF 17 26 10 HLA-B*15:01 100% (SARS-CoV)
54 E FVVFLLVTL 23 31 9 HLA-A*02:06 100% (SARS-CoV)
55 E LLFLAFVVFL 18 27 10 HLA-A*02:01 100% (SARS-CoV)
56 E VTLAILTALR 29 38 10 HLA-A*68:01 100% (SARS-CoV)
57 E SVLLFLAFV 16 24 9 HLA-A*02:01 100% (SARS-CoV)
58 M ATSRTLSYYK 171 180 10 HLA-A*11:01 100% (SARS-CoV)
59 M RFLYIIKLIF 44 53 10 HLA-A*23:01 90% (SARS-CoV)
60 M QWNLVIGFLF 19 28 10 HLA-A*23:01 100% (SARS-CoV)
61 M TLACFVLAAV 61 70 10 HLA-A*02:03 100% (SARS-CoV)
62 M LLWPVTLACF 56 65 10 HLA-B*15:01 100% (SARS-CoV)
63 M SELVIGAVIL 136 145 10 HLA-B*40:01 90% (SARS-CoV)
64 M ATSRTLSYYK 171 180 10 HLA-A*03:01 100% (SARS-CoV)
65 M FLFLTWICLL 26 35 10 HLA-A*02:01 80% (SARS-CoV)
66 M MACLVGLMW 84 92 9 HLA-B*57:01 88.89% (SARS-CoV)
67 M ELVIGAVILR 137 146 10 HLA-A*68:01 90% (SARS-CoV)
68 M LVIGAVILR 138 146 9 HLA-A*68:01 88.89% (SARS-CoV)
69 M SELVIGAVI 136 144 9 HLA-B*40:01 100% (SARS-CoV)
70 M KLIFLWLLW 50 58 9 HLA-B*58:01 88.89% (SARS-CoV)
71 M MACLVGLMW 84 92 9 HLA-B*58:01 88.89% (SARS-CoV)
72 M TLACFVLAAV 61 70 10 HLA-A*02:01 100% (SARS-CoV)
73 M GTITVEELKK 6 15 10 HLA-A*11:01 90% (SARS-CoV)
74 M ASFRLFARTR 98 107 10 HLA-A*31:01 100% (SARS-CoV)
75 M FLYIIKLIFL 45 54 10 HLA-A*02:01 90% (SARS-CoV)
76 M KLIFLWLLW 50 58 9 HLA-A*32:01 88.89% (SARS-CoV)
77 M TSRTLSYYK 172 180 9 HLA-A*30:01 100% (SARS-CoV)
78 M SGFAAYSRYR 191 200 10 HLA-A*31:01 90% (SARS-CoV)
79 M TSRTLSYYK 172 180 9 HLA-A*11:01 100% (SARS-CoV)
80 M FLFLTWICL 26 34 9 HLA-A*02:01 77.78% (SARS-CoV)
81 M FVLAAVYRI 65 73 9 HLA-A*02:01 100% (SARS-CoV)
82 M TLACFVLAA 61 69 9 HLA-A*02:03 100% (SARS-CoV)
83 M FVLAAVYRI 65 73 9 HLA-A*02:06 100% (SARS-CoV)
84 M GTITVEELK 6 14 9 HLA-A*68:01 100% (SARS-CoV)
85 M FAAYSRYRI 193 201 9 HLA-A*68:02 88.89% (SARS-CoV)
86 M TLACFVLAAV 61 70 10 HLA-A*02:06 100% (SARS-CoV)
87 M TLACFVLAAV 61 70 10 HLA-A*68:02 100% (SARS-CoV)
88 M FLFLTWICLL 26 35 10 HLA-A*02:03 80% (SARS-CoV)
89 N KTFPPTEPK 361 369 9 HLA-A*11:01 100% (SARS-CoV)
90 N AQFAPSASAF 305 314 10 HLA-B*15:01 100% (SARS-CoV)
91 N SPRWYFYYL 105 113 9 HLA-B*07:02 100% (SARS-CoV), 88.89% (OC43), 88.89% (HKU1)
92 N KTFPPTEPK 361 369 9 HLA-A*30:01 100% (SARS-CoV)
93 N SPRWYFYYL 105 113 9 HLA-B*08:01 100% (SARS-CoV), 88.89% (OC43), 88.89% (HKU1)
94 N KTFPPTEPKK 361 370 10 HLA-A*11:01 100% (SARS-CoV)
95 N GMSRIGMEV 316 324 9 HLA-A*02:03 100% (SARS-CoV)
96 Leade VMVELVAEL 84 92 9 HLA-A*02:01 66.67% (SARS-CoV)
97 Leade VMVELVAEL 84 92 9 HLA-A*02:03 66.67% (SARS-CoV)
98 Leade VMVELVAEL 84 92 9 HLA-A*02:06 66.67% (SARS-CoV)
99 Leade ELEGIQYGR 91 99 9 HLA-A*68:01 77.78% (SARS-CoV)
100 Leade IPVAYRKVL 114 122 9 HLA-B*07:02 66.67% (SARS-CoV)
101 NSP2 TLSEQLDFI 214 222 9 HLA-A*02:03 88.89% (SARS-CoV)
102 NSP2 RIRSVYPVA 299 307 9 HLA-A*30:01 100% (SARS-CoV)
103 NSP2 ETSWQTGDFV 328 337 10 HLA-A*68:02 70% (SARS-CoV)
104 NSP2 WQTGDFVKA 331 339 9 HLA-A*02:06 77.78% (SARS-CoV)
105 NSP2 SEVGPEHSL 376 384 9 HLA-B*40:01 66.67% (SARS-CoV)
106 NSP2 KLNEEIAII 468 476 9 HLA-A*02:03 77.78% (SARS-CoV)
107 NSP2 EEIAIILASF 471 480 10 HLA-B*44:03 90% (SARS-CoV)
108 NSP2 EEIAIILASF 471 480 10 HLA-B*44:02 90% (SARS-CoV)
109 NSP2 ETVKGLDYK 489 497 9 HLA-A*68:01 66.67% (SARS-CoV)
110 NSP2 VVMAYITGGV 596 605 10 HLA-A*02:03 60% (SARS-CoV)
111 NSP2 VVMAYITGGV 596 605 10 HLA-A*68:02 60% (SARS-CoV)
112 NSP2 FKLVNKFLAL 679 688 10 HLA-A*02:06 50% (SARS-CoV)
113 NSP2 ALNLGETFV 702 710 9 HLA-A*02:03 66.67% (SARS-CoV)
114 NSP2 EETGLLMPL 725 733 9 HLA-B*40:01 66.67% (SARS-CoV)
115 NSP2/ TLKGGAPTKV 814 823 10 HLA-A*02:03 70% (SARS-CoV)
116 NSP3 EFACVVADAV 870 879 10 HLA-A*68:02 90% (SARS-CoV)
117 NSP3 EWSMATYYLF 899 908 10 HLA-A*23:01 80% (SARS-CoV)
118 NSP3 EWSMATYYLF 899 908 10 HLA-A*24:02 80% (SARS-CoV)
119 NSP3 GEFKLASHM 912 920 9 HLA-B*40:01 44.44% (SARS-CoV)
120 NSP3 KLVSSFLEMK 1185 1194 10 HLA-A*03:01 50% (SARS-CoV)
121 NSP3 LVSSFLEMK 1186 1194 9 HLA-A*11:01 55.56% (SARS-CoV)
122 NSP3 SSFLEMKSEK 1188 1197 10 HLA-A*11:01 50% (SARS-CoV)
123 NSP3 FITESKPSV 1214 1222 9 HLA-A*02:06 66.67% (SARS-CoV)
124 NSP3 ESKPSVEQR 1217 1225 9 HLA-A*68:01 55.56% (SARS-CoV)
125 NSP3 LVSDIDITF 1270 1278 9 HLA-B*35:01 66.67% (SARS-CoV)
126 NSP3 VSDIDITFLK 1271 1280 10 HLA-A*11:01 70% (SARS-CoV)
127 NSP3 SDIDITFLK 1272 1280 9 HLA-A*11:01 66.67% (SARS-CoV)
128 NSP3 SDIDITFLK 1272 1280 9 HLA-A*68:01 66.67% (SARS-CoV)
129 NSP3 LTAVVIPTKK 1296 1305 10 HLA-A*68:01 70% (SARS-CoV)
130 NSP3 QEILGTVSW 1365 1373 9 HLA-B*44:02 88.89% (SARS-CoV)
131 NSP3 QEILGTVSW 1365 1373 9 HLA-B*44:03 88.89% (SARS-CoV)
132 NSP3 TLVTMPLGYV 1444 1453 10 HLA-A*02:03 80% (SARS-CoV)
133 NSP3 TLVTMPLGYV 1444 1453 10 HLA-A*02:01 80% (SARS-CoV)
134 NSP3 ETISLAGSYK 1503 1512 10 HLA-A*68:01 80% (SARS-CoV)
135 NSP3 GQSTQLGIEF 1518 1527 10 HLA-B*15:01 70% (SARS-CoV)
136 NSP3 STQLGIEFLK 1520 1529 10 HLA-A*11:01 70% (SARS-CoV)
137 NSP3 EYYHTTDPSF 1633 1642 10 HLA-A*23:01 80% (SARS-CoV)
138 NSP3 HTTDPSFLGR 1636 1645 10 HLA-A*68:01 80% (SARS-CoV)
139 NSP3 RYMSALNHTK 1645 1654 10 HLA-A*03:01 100% (SARS-CoV)
140 NSP3 MSALNHTKK 1647 1655 9 HLA-A*68:01 100% (SARS-CoV)
141 NSP3 NPPALQDAY 1691 1699 9 HLA-B*35:01 77.78% (SARS-CoV)
142 NSP3 GEAANFCAL 1705 1713 9 HLA-B*40:01 88.89% (SARS-CoV)
143 NSP3 EAANFCALI 1706 1714 9 HLA-A*68:02 88.89% (SARS-CoV)
144 NSP3 ESPFVMMSA 1801 1809 9 HLA-A*68:02 88.89% (SARS-CoV)
145 NSP3 FVMMSAPPA 1804 1812 9 HLA-A*02:06 100% (SARS-CoV)
146 NSP3 AQYELKHGTF 1812 1821 10 HLA-B*15:01 60% (SARS-CoV)
147 NSP3 NSYTTTIKPV 1871 1880 10 HLA-A*68:02 90% (SARS-CoV)
148 NSP3 TTTIKPVTYK 1874 1883 10 HLA-A*11:01 90% (SARS-CoV)
149 NSP3 TTTIKPVTYK 1874 1883 10 HLA-A*68:01 90% (SARS-CoV)
150 NSP3 TTIKPVTYK 1875 1883 9 HLA-A*11:01 88.89% (SARS-CoV)
151 NSP3 TTIKPVTYK 1875 1883 9 HLA-A*68:01 88.89% (SARS-CoV)
152 NSP3 KPVETSNSF 2017 2025 9 HLA-B*35:01 88.89% (SARS-CoV)
153 NSP3 YMPYFFTLLL 2168 2177 10 HLA-A*02:03 80% (SARS-CoV)
154 NSP3 MPYFFTLLL 2169 2177 9 HLA-B*53:01 77.78% (SARS-CoV)
155 NSP3 MPYFFTLLL 2169 2177 9 HLA-B*35:01 77.78% (SARS-CoV)
156 NSP3 IIIWFLLLSV 2229 2238 10 HLA-A*02:03 60% (SARS-CoV)
157 NSP3 IIWFLLLSV 2230 2238 9 HLA-A*02:01 55.56% (SARS-CoV)
158 NSP3 LLSVCLGSL 2235 2243 9 HLA-A*02:03 88.89% (SARS-CoV)
159 NSP3 SLIYSTAAL 2242 2250 9 HLA-A*02:03 66.67% (SARS-CoV)
160 NSP3 LMSNLGMPSY 2253 2262 10 HLA-B*15:01 70% (SARS-CoV)
161 NSP3 MSNLGMPSY 2254 2262 9 HLA-A*30:02 66.67% (SARS-CoV)
162 NSP3 MSNLGMPSY 2254 2262 9 HLA-B*35:01 66.67% (SARS-CoV)
163 NSP3 YLNSTNVTIA 2270 2279 10 HLA-A*02:03 70% (SARS-CoV)
164 NSP3 ETIQITISS 2305 2313 9 HLA-A*68:02 88.89% (SARS-CoV)
165 NSP3 TIQITISSFK 2306 2315 10 HLA-A*68:01 80% (SARS-CoV)
166 NSP3 TIQITISSFK 2306 2315 10 HLA-A*11:01 80% (SARS-CoV)
167 NSP3 TIQITISSFK 2306 2315 10 HLA-A*03:01 80% (SARS-CoV)
168 NSP3 TAFGLVAEW 2319 2327 9 HLA-B*57:01 66.67% (SARS-CoV)
169 NSP3 TAFGLVAEW 2319 2327 9 HLA-B*58:01 66.67% (SARS-CoV)
170 NSP3 WFLAYILFTR 2327 2336 10 HLA-A*33:01 70% (SARS-CoV)
171 NSP3 FLAYILFTR 2328 2336 9 HLA-A*68:01 66.67% (SARS-CoV)
172 NSP3 FLAYILFTR 2328 2336 9 HLA-A*31:01 66.67% (SARS-CoV)
173 NSP3 LFFSYFAVHF 2349 2358 10 HLA-A*23:01 70% (SARS-CoV)
174 NSP3 WLMWLIINLV 2363 2372 10 HLA-A*02:01 70% (SARS-CoV)
175 NSP3 WLMWLIINLV 2363 2372 10 HLA-A*02:03 70% (SARS-CoV)
176 NSP3 WLMWLIINL 2363 2371 9 HLA-A*02:01 66.67% (SARS-CoV)
177 NSP3 WLMWLIINLV 2363 2372 10 HLA-A*02:06 70% (SARS-CoV)
178 NSP3 WLMWLIINL 2363 2371 9 HLA-A*02:03 66.67% (SARS-CoV)
179 NSP3 WLMWLIINL 2363 2371 9 HLA-A*02:06 66.67% (SARS-CoV)
180 NSP3 LMWLIINLV 2364 2372 9 HLA-A*02:01 66.67% (SARS-CoV)
181 NSP3 LVQMAPISAM 2371 2380 10 HLA-B*15:01 80% (SARS-CoV)
182 NSP3 VQMAPISAM 2372 2380 9 HLA-B*15:01 88.89% (SARS-CoV)
183 NSP3 VQMAPISAMV 2372 2381 10 HLA-A*02:03 90% (SARS-CoV)
184 NSP3 VQMAPISAM 2372 2380 9 HLA-A*02:06 88.89% (SARS-CoV)
185 NSP3 QMAPISAMV 2373 2381 9 HLA-A*02:03 88.89% (SARS-CoV)
186 NSP3 QMAPISAMV 2373 2381 9 HLA-A*02:06 88.89% (SARS-CoV)
187 NSP3 ESSAKSASV 2551 2559 9 HLA-A*68:02 77.78% (SARS-CoV)
188 NSP3 AELAKNVSL 2618 2626 9 HLA-B*40:01 66.67% (SARS-CoV)
189 NSP3 FISAARQGFV 2633 2642 10 HLA-A*02:03 80% (SARS-CoV)
190 NSP3 ETKDVVECLK 2647 2656 10 HLA-A*68:01 80% (SARS-CoV)
191 NSP3 DFMSLSEQLR 2717 2726 10 HLA-A*33:01 90% (SARS-CoV)
192 NSP3 MSLSEQLRK 2719 2727 9 HLA-A*11:01 100% (SARS-CoV)
193 NSP3 AKKNNLPFK 2733 2741 9 HLA-A*30:01 77.78% (SARS-CoV)
194 NSP3 NVVTTKIALK 2752 2761 10 HLA-A*68:01 80% (SARS-CoV)
195 NSP4 KQLIKVTLVF 2771 2780 10 HLA-B*15:01 50% (SARS-CoV)
196 NSP4 QLIKVTLVF 2772 2780 9 HLA-B*15:01 55.56% (SARS-CoV)
197 NSP4 KVTLVFLFV 2775 2783 9 HLA-A*02:06 55.56% (SARS-CoV)
198 NSP4 FLFVAAIFYL 2780 2789 10 HLA-A*02:01 60% (SARS-CoV)
199 NSP4 FLFVAAIFYL 2780 2789 10 HLA-A*02:06 60% (SARS-CoV)
200 NSP4 FLFVAAIFYL 2780 2789 10 HLA-A*02:03 60% (SARS-CoV)
201 NSP4 LIAAVITREV 2853 2862 10 HLA-A*02:03 60% (SARS-CoV)
202 NSP4 FVVPGLPGT 2864 2872 9 HLA-A*02:06 88.89% (SARS-CoV)
203 NSP4 SLRPDTRYV 2947 2955 9 HLA-A*02:03 88.89% (SARS-CoV)
204 NSP4 IVAGGIVAIV 3047 3056 10 HLA-A*02:03 70% (SARS-CoV)
205 NSP4 LAYYFMRFRR 3060 3069 10 HLA-A*31:01 80% (SARS-CoV)
206 NSP4 LAYYFMRFR 3060 3068 9 HLA-A*31:01 77.78% (SARS-CoV)
207 NSP4 LAYYFMRFR 3060 3068 9 HLA-A*68:01 77.78% (SARS-CoV)
208 NSP4 LAYYFMRFR 3060 3068 9 HLA-A*33:01 77.78% (SARS-CoV)
209 NSP4 LAYYFMRFRR 3060 3069 10 HLA-A*68:01 80% (SARS-CoV)
210 NSP4 TLLFLMSFTV 3082 3091 10 HLA-A*02:01 80% (SARS-CoV)
211 NSP4 LLFLMSFTV 3083 3091 9 HLA-A*02:01 88.89% (SARS-CoV)
212 NSP4 LLFLMSFTV 3083 3091 9 HLA-A*02:06 88.89% (SARS-CoV)
213 NSP4 LLFLMSFTV 3083 3091 9 HLA-A*02:03 88.89% (SARS-CoV)
214 NSP4 FLMSFTVLCL 3085 3094 10 HLA-A*02:01 90% (SARS-CoV)
215 NSP4 FLMSFTVLCL 3085 3094 10 HLA-A*02:03 90% (SARS-CoV)
216 NSP4 SVIYLYLTF 3106 3114 9 HLA-A*32:01 88.89% (SARS-CoV)
217 NSP4 SVIYLYLTFY 3106 3115 10 HLA-A*11:01 90% (SARS-CoV)
218 NSP4 YLYLTFYLT 3109 3117 9 HLA-A*02:01 88.89% (SARS-CoV)
219 NSP4 TFYLTNDVSF 3113 3122 10 HLA-A*23:01 90% (SARS-CoV)
220 NSP4 YLTNDVSFLA 3115 3124 10 HLA-A*02:01 90% (SARS-CoV)
221 NSP4 VSFLAHIQW 3120 3128 9 HLA-B*57:01 88.89% (SARS-CoV)
222 NSP4 VSFLAHIQW 3120 3128 9 HLA-B*58:01 88.89% (SARS-CoV)
223 NSP4 FTPLVPFWI 3132 3140 9 HLA-A*68:02 77.78% (SARS-CoV)
224 NSP4 VPFWITIAY 3136 3144 9 HLA-B*35:01 77.78% (SARS-CoV)
225 NSP4 CISTKHFYW 3147 3155 9 HLA-B*58:01 66.67% (SARS-CoV)
226 NSP4 FLLNKEMYL 3183 3191 9 HLA-A*02:01 100% (SARS-CoV)
227 NSP4 LPLTQYNRY 3199 3207 9 HLA-B*35:01 100% (SARS-CoV)
228 3C-li KMAFPSGKV 3268 3276 9 HLA-A*02:03 100% (SARS-CoV)
229 3C-li TTLNDFNLV 3488 3496 9 HLA-A*02:06 100% (SARS-CoV)
230 3C-li EFTPFDVVR 3553 3561 9 HLA-A*33:01 100% (SARS-CoV)
231 3C-li EFTPFDVVR 3553 3561 9 HLA-A*68:01 100% (SARS-CoV)
232 NSP6 TQWSLFFFL 3598 3606 9 HLA-A*02:06 88.89% (SARS-CoV)
233 NSP6 TQWSLFFFL 3598 3606 9 HLA-A*02:01 88.89% (SARS-CoV)
234 NSP6 TQWSLFFFLY 3598 3607 10 HLA-B*15:01 90% (SARS-CoV)
235 NSP6 LYENAFLPF 3606 3614 9 HLA-A*23:01 88.89% (SARS-CoV)
236 NSP6 FLPFAMGII 3611 3619 9 HLA-A*02:03 66.67% (SARS-CoV)
237 NSP6 AMGIIAMSAF 3615 3624 10 HLA-B*15:01 50% (SARS-CoV)
238 NSP6 AMSAFAMMFV 3620 3629 10 HLA-A*02:01 50% (SARS-CoV)
239 NSP6 AMSAFAMMFV 3620 3629 10 HLA-A*02:03 50% (SARS-CoV)
240 NSP6 MSAFAMMFVK 3621 3630 10 HLA-A*11:01 50% (SARS-CoV)
241 NSP6 MSAFAMMFVK 3621 3630 10 HLA-A*03:01 50% (SARS-CoV)
242 NSP6 MSAFAMMFVK 3621 3630 10 HLA-A*68:01 50% (SARS-CoV)
243 NSP6 MSAFAMMFV 3621 3629 9 HLA-A*68:02 55.56% (SARS-CoV)
244 NSP6 MSAFAMMFV 3621 3629 9 HLA-A*02:06 55.56% (SARS-CoV)
245 NSP6 SAFAMMFVK 3622 3630 9 HLA-A*11:01 55.56% (SARS-CoV)
246 NSP6 SAFAMMFVK 3622 3630 9 HLA-A*68:01 55.56% (SARS-CoV)
247 NSP6 MMFVKHKHAF 3626 3635 10 HLA-B*15:01 80% (SARS-CoV)
248 NSP6 FLCLFLLPSL 3635 3644 10 HLA-A*02:01 100% (SARS-CoV)
249 NSP6 FLCLFLLPSL 3635 3644 10 HLA-A*02:06 100% (SARS-CoV)
250 NSP6 FLLPSLATV 3639 3647 9 HLA-A*02:03 100% (SARS-CoV)
251 NSP6 FLLPSLATV 3639 3647 9 HLA-A*02:06 100% (SARS-CoV)
252 NSP6 FLLPSLATV 3639 3647 9 HLA-A*02:01 100% (SARS-CoV)
253 NSP6 FLLPSLATVA 3639 3648 10 HLA-A*02:03 100% (SARS-CoV)
254 NSP6 VYMPASWVMR 3653 3662 10 HLA-A*31:01 100% (SARS-CoV)
255 NSP6 MPASWVMRIM 3655 3664 10 HLA-B*07:02 100% (SARS-CoV)
256 NSP6 MPASWVMRI 3655 3663 9 HLA-B*53:01 100% (SARS-CoV)
257 NSP6 CVMYASAVV 3682 3690 9 HLA-A*68:02 88.89% (SARS-CoV)
258 NSP6 LLILMTARTV 3691 3700 10 HLA-A*02:03 100% (SARS-CoV)
259 NSP6 LILMTARTVY 3692 3701 10 HLA-B*15:01 100% (SARS-CoV)
260 NSP6 ILMTARTVY 3693 3701 9 HLA-B*15:01 100% (SARS-CoV)
261 NSP6 WTLMNVLTLV 3709 3718 10 HLA-A*02:06 90% (SARS-CoV)
262 NSP6 NALDQAISM 3725 3733 9 HLA-B*35:01 100% (SARS-CoV)
263 NSP6 ALIISVTSNY 3735 3744 10 HLA-B*15:01 90% (SARS-CoV)
264 NSP6 VMFLARGIVF 3751 3760 10 HLA-B*15:01 80% (SARS-CoV)
265 NSP6 FLARGIVFM 3753 3761 9 HLA-A*02:01 77.78% (SARS-CoV)
266 NSP6 FLARGIVFM 3753 3761 9 HLA-A*02:03 77.78% (SARS-CoV)
267 NSP6 FLARGIVFM 3753 3761 9 HLA-A*02:06 77.78% (SARS-CoV)
268 NSP6 NTLQCIMLV 3774 3782 9 HLA-A*02:06 100% (SARS-CoV)
269 NSP6 RYFRLTLGVY 3802 3811 10 HLA-A*30:02 100% (SARS-CoV)
270 NSP6 LTLGVYDYLV 3806 3815 10 HLA-A*02:06 100% (SARS-CoV)
271 NSP6 DYLVSTQEFR 3812 3821 10 HLA-A*33:01 100% (SARS-CoV), 80% (MERS-CoV)
272 NSP6 YLVSTQEFR 3813 3821 9 HLA-A*68:01 100% (SARS-CoV)
273 NSP7 LLAKDTTEA 3899 3907 9 HLA-A*02:03 100% (SARS-CoV)
274 NSP8 SLPSYAAFA 3950 3958 9 HLA-A*02:03 88.89% (SARS-CoV)
275 NS8/N LQNNELSPV 4139 4147 9 HLA-A*02:06 100% (SARS-CoV)
276 NS8/N LQNNELSPV 4139 4147 9 HLA-A*02:03 100.00%
277 NSP9 LSDLQDLKW 4185 4193 9 HLA-B*58:01 88.89% (SARS-CoV)
278 NSP9 DLQDLKWAR 4187 4195 9 HLA-A*33:01 88.89% (SARS-CoV)
279 NSP9 KVKYLYFIK 4224 4232 9 HLA-A*30:01 100% (SARS-CoV), 88.89% (HKU1)
280 NSP9 KVKYLYFIK 4224 4232 9 HLA-A*11:01 100% (SARS-CoV), 88.89% (HKU1)
281 NSP9 KVKYLYFIK 4224 4232 9 HLA-A*31:01 100% (SARS-CoV), 88.89% (HKU1)
282 NSP9 MVLGSLAATV 4241 4250 10 HLA-A*02:06 100% (SARS-CoV)
283 NSP9 MVLGSLAATV 4241 4250 10 HLA-A*02:03 100% (SARS-CoV)
284 NSP9 VLGSLAATV 4242 4250 9 HLA-A*02:03 100% (SARS-CoV)
285 NSP10 TVLSFCAFAV 4265 4274 10 HLA-A*02:06 100% (SARS-CoV)
286 NSP10 TVCTVCGMWK 4368 4377 10 HLA-A*11:01 100% (SARS-CoV)
287 RDRP RVCGVSAAR 4402 4410 9 HLA-A*31:01 100% (SARS-CoV)
288 RDRP MVPHISRQR 4502 4510 9 HLA-A*68:01 100% (SARS-CoV)
289 RDRP TMADLVYALR 4515 4524 10 HLA-A*68:01 100% (SARS-CoV), 90% (MERS-CoV), 80% (NL63), 80% (OC43), 80% (HKU1)
290 RDRP AMRNAGIVGV 4587 4596 10 HLA-A*02:03 90% (SARS-CoV)
291 RDRP LLMPILTLT 4632 4640 9 HLA-A*02:03 100% (SARS-CoV)
292 RDRP LLMPILTLT 4632 4640 9 HLA-A*02:01 100% (SARS-CoV)
293 RDRP ILHCANFNV 4699 4707 9 HLA-A*02:01 100% (SARS-CoV), 88.89% (MERS-CoV)
294 RDRP ILHCANFNV 4699 4707 9 HLA-A*02:03 100% (SARS-CoV), 88.89% (MERS-CoV)
295 RDRP VPFVVSTGY 4730 4738 9 HLA-B*35:01 100% (SARS-CoV), 88.89% (OC43), 88.89% (MERS-CoV), 88.89% (HKU1)
296 RDRP RLSFKELLVY 4757 4766 10 HLA-B*15:01 100% (SARS-CoV)
297 RDRP LSFKELLVY 4758 4766 9 HLA-B*15:01 100% (SARS-CoV)
298 RDRP AMHAASGNL 4771 4779 9 HLA-A*02:03 100% (SARS-CoV)
299 RDRP RQLLFVVEV 4859 4867 9 HLA-A*02:06 100% (SARS-CoV)
300 RDRP FVVEVVDKY 4863 4871 9 HLA-B*35:01 100% (SARS-CoV)
301 RDRP KSAGFPFNK 4892 4900 9 HLA-A*11:01 100% (SARS-CoV), 88.89% (OC43), 88.89% (MERS-CoV), 88.89% (HKU1)
302 RDRP KSAGFPFNK 4892 4900 9 HLA-A*03:01 100% (SARS-CoV), 88.89% (OC43), 88.89% (MERS-CoV), 88.89% (HKU1)
303 RDRP ALFAYTKRNV 4918 4927 10 HLA-A*02:03 100% (SARS-CoV), 90% (NL63), 80% (MERS-CoV)
304 RDRP MTNRQFHQK 4958 4966 9 HLA-A*11:01 100% (SARS-CoV), 88.89% (MERS-CoV), 88.89% (229E)
305 RDRP MTNRQFHQK 4958 4966 9 HLA-A*68:01 100% (SARS-CoV), 88.89% (MERS-CoV), 88.89% (229E)
306 RDRP MTNRQFHQK 4958 4966 9 HLA-A*31:01 100% (SARS-CoV), 88.89% (MERS-CoV), 88.89% (229E)
307 RDRP MTNRQFHQK 4958 4966 9 HLA-A*30:01 100% (SARS-CoV), 88.89% (MERS-CoV), 88.89% (229E)
308 RDRP NPHLMGWDY 5003 5011 9 HLA-B*35:01 100% (MERS-CoV), 88.89% (SARS-CoV), 88.8% (OC43), 88.89% (NL63), 88.89% (HKU1)
309 RDRP MASLVLARK 5025 5033 9 HLA-A*68:01 100.00%
310 RDRP VMCGGSLYVK 5059 5068 10 HLA-A*03:01 100% (SARS-CoV), 80% (MERS-CoV), 80% (HKU1)
311 RDRP VMCGGSLYVK 5059 5068 10 HLA-A*11:01 100% (SARS-CoV), 80% (MERS-CoV), 80% (HKU1)
312 RDRP YLRKHFSMM 5140 5148 9 HLA-B*08:01 100% (SARS-CoV), 100% (NL63), 88.89% (229E)
313 RDRP LVASIKNFK 5167 5175 9 HLA-A*68:01 100.00%
314 RDRP SVLYYQNNVF 5176 5185 10 HLA-B*15:01 90% (SARS-CoV), 90% (HKU1), 90% (OC43), 80% (MERS-CoV), 80% (NL63)
315 RDRP HLYLQYIRK 5274 5282 9 HLA-A*03:01 100% (SARS-CoV), 90% (OC43), 90% (HKU1), 80% (MERS-CoV)
316 Helic QLYLGGMSYY 5386 5395 10 HLA-A*03:01 100% (SARS-CoV), 90% (OC43), 90% (HKU1), 80% (MERS-CoV)
317 Helic QLYLGGMSYY 5386 5395 10 HLA-B*15:01 100% (SARS-CoV)
318 Helic LSYGIATVR 5471 5479 9 HLA-A*68:01 100% (SARS-CoV)
319 Helic REVLSDREL 5479 5487 9 HLA-B*40:01 100% (SARS-CoV)
320 Helic RNYVFTGYR 5502 5510 9 HLA-A*31:01 100% (SARS-CoV), 88.89% (MERS-CoV)
321 Helic YVFTGYRVTK 5504 5513 10 HLA-A*68:01 100% (SARS-CoV), 80% (MERS-CoV), 80% (OC43)
322 Helic KVQIGEYTF 5516 5524 9 HLA-A*32:01 100% (SARS-CoV)
323 Helic KLNVGDYFV 5542 5550 9 HLA-A*02:01 100% (SARS-CoV)
324 Helic KLNVGDYFV 5542 5550 9 HLA-A*02:03 100% (SARS-CoV)
325 Helic YPTLNISDEF 5577 5586 10 HLA-B*35:01 100% (SARS-CoV)
326 Helic SSNVANYQK 5587 5595 9 HLA-A*11:01 100% (SARS-CoV)
327 Helic FAIGLALYY 5615 5623 9 HLA-B*53:01 100% (SARS-CoV), 88.89% (MERS-CoV)
328 Helic FAIGLALYY 5615 5623 9 HLA-B*35:01 100% (SARS-CoV), 88.89% (MERS-CoV)
329 Helic TTADIVVFD 5690 5698 9 HLA-A*68:02 100.00%
330 Helic SMATNYDLSV 5701 5710 10 HLA-A*02:03 100% (SARS-CoV), 90% (NL63), 90% (229E), 80% (OC43), 80% (MERS-CoV), 80% (HKU1)
331 Helic SVVNARLRAK 5709 5718 10 HLA-A*11:01 100% (SARS-CoV), 80% (OC43)
332 Helic KDKSAQCFK 5789 5797 9 HLA-A*30:01 100.00%
333 Helic SSQGSEYDY 5859 5867 9 HLA-A*30:02 100% (SARS-CoV), 100% (NL63), 88.89% (229E), 88.89% (OC43), 88.89% (MERS-CoV), 88.89% (HKU1)
334 Helic NVAITRAKV 5886 5894 9 HLA-A*68:02 88.89% (SARS-CoV), 88.89% (NL63), 88.89% (OC43), 88.89% (HKU1), 88.89% (229E)
335 Helic KLQFTSLEI 5908 5916 9 HLA-A*32:01 100% (SARS-CoV)
336 Helic FTSLEIPRR 5911 5919 9 HLA-A*68:01 100% (SARS-CoV)
337 3'-5' RLISMMGFK 5978 5986 9 HLA-A*03:01 100% (SARS-CoV), 88.89% (OC43), 88.89%(HKU1)
338 3'-5' ISMMGFKMNY 5980 5989 10 HLA-B*15:01 100% (SARS-CoV)
339 3'-5' LQLGFSTGV 6032 6040 9 HLA-A*02:06 100% (SARS-CoV),100% (MERS-CoV), 88.89% (OC43), 88.89%(HKU1)
340 3'-5' IPLMYKGLPW 6075 6084 10 HLA-B*53:01 100% (SARS-CoV)
341 3'-5' NLSDRVVFV 6101 6109 9 HLA-A*02:03 88.89% (SARS-CoV)
342 3'-5' NLSDRVVFV 6101 6109 9 HLA-A*02:01 88.89% (SARS-CoV)
343 3'-5' NLSDRVVFV 6101 6109 9 HLA-A*02:06 88.89% (SARS-CoV)
344 3'-5' HSIGFDYVY 6154 6162 9 HLA-B*35:01 88.89% (SARS-CoV)
345 3'-5' KQLPFFYYS 6365 6373 9 HLA-A*02:06 100% (SARS-CoV), 88.89% (MERS-CoV)
346 3'-5' KQVVSDIDYV 6382 6391 10 HLA-A*02:06 100% (SARS-CoV)
347 3'-5' QVVSDIDYV 6383 6391 9 HLA-A*02:06 100% (SARS-CoV)
348 3'-5' NMMISAGFSL 6424 6433 10 HLA-A*02:01 100% (SARS-CoV)
349 3'-5' MMISAGFSL 6425 6433 9 HLA-A*02:06 100% (SARS-CoV)
350 3'-5' MMISAGFSL 6425 6433 9 HLA-A*02:01 100% (SARS-CoV)
351 3'-5' MMISAGFSL 6425 6433 9 HLA-A*02:03 100% (SARS-CoV)
352 3'-5' MISAGFSLW 6426 6434 9 HLA-B*58:01 100% (SARS-CoV)
353 3'-5' RLQSLENVAF 6450 6459 10 HLA-B*15:01 90% (SARS-CoV), 80% (NL63)
354 3'-5' LQSLENVAF 6451 6459 9 HLA-B*15:01 88.89% (SARS-CoV), 88.89% (NL63)
355 Endo- NVAFNVVNK 6456 6464 9 HLA-A*68:01 88.89% (SARS-CoV), 88.89% (229E)
356 Endo- NTVIWDYKR 6534 6542 9 HLA-A*68:01 100% (SARS-CoV)
357 Endo- ETICAPLTV 6565 6573 9 HLA-A*68:02 55.56% (SARS-CoV)
358 Endo- AVKTQFNYYK 6623 6632 10 HLA-A*11:01 80% (SARS-CoV)
359 Endo- SQLGGLHLL 6695 6703 9 HLA-A*02:06 77.78% (SARS-CoV)
360 Endo- VTIDYTEISF 6772 6781 10 HLA-B*15:01 90% (SARS-CoV)
361 2'-O- LTLAVPYNMR 6855 6864 10 HLA-A*68:01 100% (SARS-CoV), 80% (MERS-CoV), 80% (HKU1), 80% (OC43)
362 2'-O- TLAVPYNMRV 6856 6865 10 HLA-A*02:03 100% (SARS-CoV), 90% (MERS-CoV), 90% (OC43), 90% (HKU1), 90% (229E)
363 2'-O- HFAWWTAFV 6984 6992 9 HLA-A*68:02 88.89% (SARS-CoV)
364 2'-O- VMHANYIFWR 7021 7030 10 HLA-A*31:01 90% (SARS-CoV), 90% (HKU1), 90% (OC43), 90% (MERS-CoV), 80% (NL63)
365 2'-O- MHANYIFWR 7022 7030 9 HLA-A*68:01 90% (SARS-CoV), 90% (HKU1), 90% (OC43), 90% (MERS-CoV), 80% (NL63)
366 2'-O- SSYSLFDMSK 7038 7047 10 HLA-A*11:01 100% (SARS-CoV), 80% (MERS-CoV)
367 2'-O- MSKFPLKLR 7045 7053 9 HLA-A*31:01 100% (SARS-CoV)
368 2'-O- RLIIRENNR 7077 7085 9 HLA-A*31:01 100% (SARS-CoV)
369 ORF3 FTIGTVTLK 8 16 9 HLA-A*68:01 44.44%
370 ORF3 HVTFFIYNK 227 235 9 HLA-A*68:01 66.67% (SARS-CoV)
371 ORF3 LIVGVALLAV 46 55 10 HLA-A*02:06 70% (SARS-CoV)
372 ORF3 DATPSDFVR 22 30 9 HLA-A*68:01 33.33%
373 ORF3 FLQSINFVR 114 122 9 HLA-A*68:01 66.67% (SARS-CoV)
374 ORF3 HVTFFIYNK 227 235 9 HLA-A*11:01 66.67%
375 ORF3 IVGVALLAVF 47 56 10 HLA-B*15:01 70% (SARS-CoV)
376 ORF3 NLLLLFVTV 82 90 9 HLA-A*02:06 88.89% (SARS-CoV)
377 ORF3 FLQSINFVR 114 122 9 HLA-A*31:01 66.67% (SARS-CoV)
378 ORF3 WLIVGVALL 45 53 9 HLA-A*02:03 66.67% (SARS-CoV)
379 ORF3 INFVRIIMR 118 126 9 HLA-A*31:01 77.78% (SARS-CoV)
380 ORF3 LIVGVALLAV 46 55 10 HLA-A*02:03 70% (SARS-CoV)
381 ORF6 SIWNLDYII 25 33 9 HLA-A*32:01 77.78% (SARS-CoV)
382 ORF6 FQVTIAEIL 7 15 9 HLA-A*02:06 100% (SARS-CoV)
383 ORF7a ITLCFTLKRK 110 119 10 HLA-A*03:01 70% (SARS-CoV)
384 ORF7a FLIVAAIVF 101 109 9 HLA-B*15:01 88.89% (SARS-CoV)
385 ORF7a FLIVAAIVFI 101 110 10 HLA-A*02:01 80% (SARS-CoV)
386 ORF7a ITLCFTLKRK 110 119 10 HLA-A*11:01 70% (SARS-CoV)
387 ORF7a SVSPKLFIR 81 89 9 HLA-A*31:01 100% (SARS-CoV)
388 ORF7a IFLIVAAIVF 100 109 10 HLA-B*15:01 80% (SARS-CoV)
389 ORF7a FITLCFTLKR 109 118 10 HLA-A*68:01 70% (SARS-CoV)
390 ORF7a SVSPKLFIR 81 89 9 HLA-A*68:01 100% (SARS-CoV)
391 ORF7a FLIVAAIVFI 101 110 10 HLA-A*02:03 80% (SARS-CoV)
392 ORF7a FLALITLAT 6 14 9 HLA-A*02:03 44.44% (SARS-CoV)
393 ORF7a LIVAAIVFI 102 110 9 HLA-A*02:06 77.78% (SARS-CoV)
394 ORF7a ILFLALITLA 4 13 10 HLA-A*02:03 60% (SARS-CoV)
395 ORF7a LTCFSTQFAF 56 65 10 HLA-B*15:01 80% (SARS-CoV)
396 ORF7b FLAFLLFLV 13 21 9 HLA-A*02:03 100% (SARS-CoV)
397 ORF7b FLAFLLFLV 13 21 9 HLA-A*02:06 100% (SARS-CoV)
398 ORF7b FLAFLLFLV 13 21 9 HLA-A*02:01 100% (SARS-CoV)
399 ORF7b FYLCFLAFLL 9 18 10 HLA-A*23:01 100% (SARS-CoV)
400 ORF7b SLIDFYLCFL 5 14 10 HLA-A*02:01 90% (SARS-CoV)
401 ORF7b MLIIFWFSL 24 32 9 HLA-A*02:01 100% (SARS-CoV)
402 ORF7b FLAFLLFLVL 13 22 10 HLA-A*02:01 100% (SARS-CoV)
403 ORF7b YLCFLAFLL 10 18 9 HLA-A*02:01 100% (SARS-CoV)
404 ORF7b FLLFLVLIML 16 25 10 HLA-A*02:01 100% (SARS-CoV)
405 ORF7b FLAFLLFLV 13 21 9 HLA-A*68:02 100% (SARS-CoV)
406 ORF7b MLIIFWFSL 24 32 9 HLA-A*02:06 100% (SARS-CoV)
407 ORF7b SLIDFYLCFL 5 14 10 HLA-A*02:03 90% (SARS-CoV)
408 ORF7b LIDFYLCFL 6 14 9 HLA-A*02:06 100% (SARS-CoV)
409 ORF8 HFYSKWYIR 40 48 9 HLA-A*31:01 22.22% (SARS-CoV)
410 ORF8 IQYIDIGNY 71 79 9 HLA-A*30:02 33.33% (SARS-CoV)
411 ORF8 HFYSKWYIR 40 48 9 HLA-A*33:01 22.22% (SARS-CoV)
412 ORF8 CPIHFYSKW 37 45 9 HLA-B*53:01 22.22% (SARS-CoV)
413 ORF8 NYTVSCLPF 78 86 9 HLA-A*23:01 33.33% (SARS-CoV)
414 ORF8 LGIITTVAAF 7 16 10 HLA-B*15:01 40% (SARS-CoV)
415 ORF8 KWYIRVGAR 44 52 9 HLA-A*31:01 33.33% (SARS-CoV)
416 ORF8 YIDIGNYTV 73 81 9 HLA-A*02:01 33.33% (SARS-CoV)
417 ORF8 FLGIITTVA 6 14 9 HLA-A*02:03 33.33% (SARS-CoV)
418 ORF8 YIDIGNYTV 73 81 9 HLA-A*02:06 33.33% (SARS-CoV)
419 ORF8 FLGIITTVAA 6 15 10 HLA-A*02:03 30% (SARS-CoV)
420 ORF10 FTIYSLLLCR 11 20 10 HLA-A*68:01 None
421 ORF10 NVFAFPFTI 5 13 9 HLA-A*68:02 None
422 ORF10 FAFPFTIYSL 7 16 10 HLA-A*02:06 None
423 ORF10 FAFPFTIYSL 7 16 10 HLA-A*02:01 None
424 ORF10 YIAQVDVVNF 26 35 10 HLA-B*15:01 None